Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Multiple Dosing Study in Asymptomatic GRN-frontotemporal Dementia Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001.

NCT06705192 is registered in ClinicalTrials.gov with Mads Kjolby as lead sponsor.

NCT NCT06705192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06705192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Multiple Dosing Study in Asymptomatic GRN-frontotemporal Dementia Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001.
Lead sponsor
Mads Kjolby
Phase
Phase 1
Overall status
Completed
Start date
December 12, 2024
Completion date
August 5, 2025
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic condition, dementia, frontotemporal dementia